Multimodality MR Imaging Findings of Low-Grade Brain Edema in Hepatic Encephalopathy

References

1. 1.↵
   1. Rovira A,
   2. Alonso J,
   3. Cordoba J

   . MR imaging findings in hepatic encephalopathy. AJNR Am J Neroradiol 2008;29:1612–21

   CrossRef
2. 2.↵
   1. Matsusue E,
   2. Kinoshita T,
   3. Ohama E,
   4. et al

   . Cerebral cortical and white matter lesions in chronic hepatic encephalopathy: MR-pathologic correlations. AJNR Am J Neuroradiol 2005;26:347–51

   Abstract/FREE Full Text
3. 3.↵
   1. Córdoba J

   . New assessment of hepatic encephalopathy. J Hepatol 2011;54:1030–40

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Poveda MJ,
   2. Bernabeu A,
   3. Concepción L,
   4. et al

   . Brain edema dynamics in patients with overt hepatic encephalopathy: a magnetic resonance imaging study. Neuroimage 2010;52:481–87

   CrossRefPubMed
5. 5.↵
   1. McPhail MJ,
   2. Taylor-Robinson SD

   . The role of magnetic resonance imaging and spectroscopy in hepatic encephalopathy. Metab Brain Dis 2010;25:65–72

   CrossRefPubMed
6. 6.↵
   1. Grover VP,
   2. Dresner MA,
   3. Forton DM,
   4. et al

   . Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy. World J Gastroenterol 2006;12:2969–78

   PubMedWeb of Science
7. 7.↵
   1. Chavarria L,
   2. Oria M,
   3. Romero-Gimenez J,
   4. et al

   . Diffusion tensor imaging supports the cytotoxic origin of brain edema in a rat model of acute liver failure. Gastroenterology 2010;138:1566–73

   CrossRefPubMed
8. 8.↵
   1. Buterworth RF

   . Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology 2011;53:1372–76

   CrossRefPubMed
9. 9.↵
   1. Rodrigo R,
   2. Cauli O,
   3. Gomez-Pinedo U,
   4. et al

   . Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology 2010;139:675–84

   CrossRefPubMed
10. 10.↵
    1. Gupta RK,
    2. Yadav SK,
    3. Rangan M,
    4. et al

    . Serum proinflammatory cytokines correlate with diffusion tensor imaging derived metrics and (1)H-MR spectroscopy in patients with acute liver failure. Metab Brain Dis 2010;25:355–61

    CrossRefPubMed
11. 11.↵
    1. Ferenci P,
    2. Lockwood A,
    3. Mullen K,
    4. et al

    . Hepatic encephalopathy: definition, nomenclature, diagnosis, and quantification—final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716–21

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Yadav SK,
    2. Saksena S,
    3. Srivastava A,
    4. et al

    . Brain MR imaging and 1H-MR spectroscopy changes in patients with extrahepatic portal vein obstruction from early childhood to adulthood. AJNR Am J Neuroradiol 2010;31:1337–42

    Abstract/FREE Full Text
13. 13.↵
    1. Randolph C,
    2. Hilsabeck R,
    3. Kato A,
    4. et al

    . Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 2009;29:629–35. Epub 2009 Mar 19

    CrossRefPubMed
14. 14.↵
    1. Zhang LJ,
    2. Yang G,
    3. Yin J,
    4. et al

    . Neural mechanism of cognitive control impairment in patients with hepatic cirrhosis: a functional magnetic resonance imaging study. Acta Radiol 2007;48:577–87

    FREE Full Text
15. 15.↵
    1. Romero-Gómez M,
    2. Córdoba J,
    3. Jover R,
    4. et al

    . Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007;45:879–85

    CrossRefPubMed
16. 16.↵
    1. Kreis R,
    2. Ross BD,
    3. Farrow NA,
    4. et al

    . Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992;182:19–27

    PubMedWeb of Science
17. 17.↵
    1. Zemtsova I,
    2. Görg B,
    3. Keitel V,
    4. et al

    . Microglia activation in hepatic encephalopathy in rats and humans. Hepatology 2011;54:204–15

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Häussinger D,
    2. Schliess F

    . Pathogenetic mechanisms of hepatic encephalopathy. Gut 2008;57:1156–65

    Abstract/FREE Full Text
19. 19.↵
    1. Arnold SM,
    2. Els T,
    3. Spreer J,
    4. et al

    . Acute hepatic encephalopathy with diffuse cortical lesions. Neuroradiology 2001;43:551–54

    CrossRefPubMedWeb of Science
20. 20.↵
    1. McKinney AM,
    2. Lohman BD,
    3. Sarikaya B,
    4. et al

    . Acute hepatic encephalopathy: diffusion-weighted and fluid-attenuated inversion recovery findings, and correlation with plasma ammonia level and clinical outcome. AJNR Am J Neuroradiol 2010;31:1471–79

    Abstract/FREE Full Text
21. 21.↵
    1. U-King-Im JM,
    2. Yu E,
    3. Bartlett E,
    4. et al

    . Acute hyperammonemic encephalopathy in adults: imaging findings. AJNR Am J Neuroradiol 2011;32:413–18

    Abstract/FREE Full Text
22. 22.↵
    1. McKinney AM,
    2. Sarikaya B,
    3. Spanbauer J,
    4. et al

    . Acute hepatic (or hyperammonemic) encephalopathy: diffuse cortical injury and the significance of ammonia. AJNR Am J Neuroradiol 2011;32:E142

    FREE Full Text
23. 23.↵
    1. Miese F,
    2. Kircheis G,
    3. Wittsack HJ,
    4. et al

    . 1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. AJNR Am J Neuroradiol 2006;27:1019–26

    Abstract/FREE Full Text
24. 24.↵
    1. Rovira A,
    2. Córdoba J,
    3. Raguer N,
    4. et al

    . Magnetic resonance imaging measurement of brain edema in patients with liver disease: resolution after transplantation. Curr Opin Neurol 2002;15:731–37

    CrossRefPubMed
25. 25.↵
    1. Barbiroli B

    . Diffusion MRI shows increased water apparent diffusion coefficient in the brains of cirrhotics. Neurology 2004;62:762–66

    CrossRef
26. 26.↵
    1. Sugimoto R,
    2. Iwasa M,
    3. Maeda M,
    4. et al

    . Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy. Am J Gastroenterol 2008;103:1413–20

    CrossRefPubMed
27. 27.↵
    1. Kale RA,
    2. Gupta RK,
    3. Saraswat VA,
    4. et al

    . Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 2006;43:698–706

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Nath K,
    2. Saraswat VA,
    3. Krishna YR,
    4. et al

    . Quantification of cerebral edema on diffusion tensor imaging in acute-on-chronic liver failure. NMR Biomed 2008;21:713–22

    CrossRefPubMed
29. 29.↵
    1. Saksena S,
    2. Rai V,
    3. Saraswat VA,
    4. et al

    . Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure. J Gastroenterol Hepatol 2008;23:e111–19

    CrossRefPubMed
30. 30.↵
    1. Rai V,
    2. Nath K,
    3. Saraswat VA,
    4. et al

    . Measurement of cytotoxic and interstitial components of cerebral edema in acute hepatic failure by diffusion tensor imaging. J Magn Reson Imaging 2008;28:334–41

    CrossRefPubMed
31. 31.↵
    1. Zhang LJ,
    2. Yin JZ,
    3. Qi J,
    4. et al

    . Metabolic changes of anterior cingulate cortex in patients with hepatic cirrhosis: a magnetic resonance spectroscopy study. Hepatol Res 2010;40:777–85

    CrossRefPubMed
32. 32.↵
    1. Mardini H,
    2. Smith FE,
    3. Record CO,
    4. et al

    . Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemia. J Hepatol 2011;54:1154–60.

    CrossRefPubMed
33. 33.↵
    1. Guevara M,
    2. Baccaro ME,
    3. Gómez-Ansón M,
    4. et al

    . Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy. J Hepatol 2011;55:564–73

    CrossRefPubMed
34. 34.↵
    1. Lee JH,
    2. Seo DW,
    3. Lee YS,
    4. et al

    . Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve. Am J Gastroenterol 1999;94:2206–13

    CrossRefPubMed
35. 35.↵
    1. Naegele T,
    2. Grodd W,
    3. Viebahn R,
    4. et al

    . MR imaging and 1H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation. Radiology 2000;216:683–91

    PubMedWeb of Science
36. 36.↵
    1. Timmermnan L,
    2. Butz M,
    3. Gross J,
    4. et al

    . Impaired cerebral oscillatory processing in hepatic encephalopathy. Clin Neurophysiol 2007; 119:265–72

    PubMed
37. 37.↵
    1. Gore JC

    . Principles and practice of functional MRI of the human brain. J Clin Invest 2003;112:4–9

    PubMedWeb of Science
38. 38.↵
    1. Zafiris O,
    2. Kircheis G,
    3. Rood HA,
    4. et al

    . Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study. Neuroimage 2004;22:541–52

    CrossRefPubMedWeb of Science
39. 39.↵
    1. Pizoli CE,
    2. Shah MN,
    3. Snyder AZ,
    4. et al

    . Resting-state activity in development and maintenance of normal brain function. Proc Natl Acad Sci U S A 2011;108:11638–43

    Abstract/FREE Full Text
40. 40.↵
    1. Rosazza C,
    2. Minati L

    . Resting-state brain networks: literature review and clinical applications. Neurol Sci 2011;32:773–85.

    CrossRefPubMed
41. 41.↵
    1. Zhang LJ,
    2. Yang G,
    3. Yin J,
    4. et al

    . Abnormal default-mode network activation in cirrhotic patients: a functional magnetic resonance imaging study. Acta Radiol 2007;48:781–87

    FREE Full Text
42. 42.↵
    1. Zhang L,
    2. Qi R,
    3. Wu S,
    4. et al

    . Brain default-mode network abnormalities in hepatic encephalopathy: a resting-state functional MRI study. Hum Brain Mapp 2013:33:1384–92